| Heated humidified high-flow nasal oxygen in adults G Spoletini, M Alotaibi, F Blasi, NS Hill Chest 148 (1), 253-261, 2015 | 458 | 2015 |
| Use of nasal high flow oxygen during acute respiratory failure JD Ricard, O Roca, V Lemiale, A Corley, J Braunlich, P Jones, BJ Kang, ... Intensive care medicine 46, 2238-2247, 2020 | 213 | 2020 |
| Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis HH Jarosz-Griffiths, T Scambler, CH Wong, S Lara-Reyna, J Holbrook, ... Elife 9, e54556, 2020 | 101 | 2020 |
| Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis G Spoletini, L Gillgrass, K Pollard, N Shaw, E Williams, C Etherington, ... Journal of Cystic Fibrosis 21 (6), 1061-1065, 2022 | 62 | 2022 |
| High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: a pilot randomized controlled trial G Spoletini, C Mega, L Pisani, M Alotaibi, A Khoja, LL Price, F Blasi, ... Journal of critical care 48, 418-425, 2018 | 57 | 2018 |
| Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series G Spoletini, C Etherington, N Shaw, IJ Clifton, M Denton, P Whitaker, ... Journal of Antimicrobial Chemotherapy 74 (5), 1425-1429, 2019 | 26 | 2019 |
| How to choose the duration of antibiotic therapy in patients with pneumonia S Aliberti, F Giuliani, J Ramirez, F Blasi, DURATION Study Group Current opinion in infectious diseases 28 (2), 177-184, 2015 | 26 | 2015 |
| Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: a narrative review G Spoletini, A Cortegiani, C Gregoretti Trends in Anaesthesia and Critical Care 26, 22-29, 2019 | 24 | 2019 |
| Noninvasive ventilatory support for acute hypercapnic respiratory failure NS Hill, G Spoletini, G Schumaker, E Garpestad Respiratory care 64 (6), 647-657, 2019 | 23 | 2019 |
| High-flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough? G Spoletini, NS Hill Annals of Thoracic Medicine 11 (3), 163-166, 2016 | 18 | 2016 |
| Noninvasive ventilation for acute hypoxemic respiratory failure/ARDS–is there a role? NS Hill, E Garpestad, G Schumaker, G Spoletini Turkish Journal of Anaesthesiology and Reanimation 45 (6), 332, 2017 | 14 | 2017 |
| Noninvasive ventilation in cystic fibrosis: clinical indications and outcomes in a large UK adult cystic fibrosis center G Spoletini, K Pollard, R Watson, MJ Darby, A Johnstone, C Etherington, ... Respiratory Care 66 (3), 466-474, 2021 | 11 | 2021 |
| High-flow nasal oxygen or noninvasive ventilation for postextubation hypoxemia: flow vs pressure? G Spoletini, E Garpestad, NS Hill JAMA 315 (13), 1340-1342, 2016 | 9 | 2016 |
| Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant P Tachtatzis, G Spoletini, I Clifton, C Etherington, D Peckham Journal of Cystic Fibrosis 23 (1), 99-102, 2024 | 8 | 2024 |
| Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: real life experience of a large adult CF centre G Spoletini, M Kennedy, L Flint, T Graham, C Etherington, N Shaw, ... Pulmonary Pharmacology & Therapeutics 50, 82-87, 2018 | 7 | 2018 |
| P206 Patient feedback following the introduction of a dedicated ‘Symkevi® Initiation Clinic’prior to starting modulator therapy L Haigh, HK Chadwick, L Gillgrass, K Pollard, N Shaw, R Watson, ... Leeds, 2021 | 6 | 2021 |
| Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis G Spoletini, G Fitch, L Gillgrass, C Etherington, I Clifton, DG Peckham ERJ Open Research 8 (2), 2022 | 5 | 2022 |
| Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial G Spoletini, R Watson, WY Lim, K Pollard, C Etherington, IJ Clifton, ... Journal of Cystic Fibrosis 20 (5), e46-e52, 2021 | 4 | 2021 |
| Better comfort and dyspnea scores with high-flow nasal cannula (HFNC) vs standard oxygen (SO) during breaks off noninvasive ventilation (NIV) G Spoletini, C Mega, A Khoja, M Alotaibi, F Blasi, S Nava, N Hill European Respiratory Journal 46 (suppl 59), 2015 | 4 | 2015 |
| Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del HH Jarosz-Griffiths, L Gillgrass, LR Caley, G Spoletini, IJ Clifton, ... Plos one 19 (5), e0304555, 2024 | 3 | 2024 |
